Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Massachusetts biopharma raised $3.45 billion in funding, marking a 25% increase from last year. The industry's strong performance indicates effective recovery and revitalized investment interest.
PRIVATEAug 25, 2026•about 5 hours ago
Amount Raised
$3.45 Billion
Round Type
Venture - Series Unknown
MassachusettsBiotechnology
Description
Massachusetts biopharma companies raised $3.45 billion in venture capital in the first half of 2026, up 25% from the same period last year. This marks the industry's strongest first half since 2023. Capital is flowing back into the sector and companies are starting to expand their workforce. Industry leaders note a notable revival in investment activity.
Company Information
Company
Massachusetts biopharma
Location
Massachusetts, United States
About
MassBio is a trade association representing more than 1,700 life sciences and biopharma organizations across Massachusetts. The organization plays a key role in tracking employment, investment, and drug development in the biopharma sector. It aims to support the growth and sustainability of the biopharmaceutical ecosystem. MassBio advocates for the industry and provides resources for its member organizations.
Don't miss Massachusetts biopharma's next move
Get an email the moment Massachusetts biopharma raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Massachusetts biopharma's next move
MassachusettsBiotechnology